Radio and PodcastRadio and PodcastLive Radio & Podcasts
Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab artwork
Health

Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab

JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the head and neck by American Medical Association

Jul 31, 202517:45Health

Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related...

About This Episode

Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab is an episode from JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the...

Podcast

This episode belongs to JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the head and neck.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jul 31, 2025, 17:45 long, audio available.

Related Episodes

Continue listening to more episodes from JAMA Otolaryngology–Head & Neck Surgery Author Interviews: Covering research, science, & clinical practice in diseases of the head and neck.